Exchange: OTC·Updated 02:17 PM EDT

About

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of PaxMedica Inc?
What is the 52-week high for PaxMedica Inc?
What is PaxMedica Inc stock price today?
What was PaxMedica Inc stock price yesterday?
What is the 50-day moving average of PaxMedica Inc?

Advertisement|Remove ads.